Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Diagnostic or test agent produces in vivo fluorescence
Patent
1994-08-22
1995-10-24
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Diagnostic or test agent produces in vivo fluorescence
424 98, 514832, A61B 100
Patent
active
054608007
ABSTRACT:
A composition for use in visualizing tissues comprising a physiologically-acceptable fluorocarbon liquid and a visualizable label such as a chromophore or visible or fluorescent dye associated therewith; preferably the fluorocarbon is in the form of an emulsion and the label has a lipophilic moiety. Also disclosed are methods for labeling and visualizing cells and tissue, such as those of the reticuloendothelial system.
REFERENCES:
patent: 4577636 (1986-03-01), Spears
patent: 4762701 (1988-08-01), Horan et al.
patent: 4783401 (1988-11-01), Horan et al.
patent: 4865836 (1989-09-01), Long, Jr.
patent: 4891208 (1990-01-01), Janoff et al.
patent: 4951673 (1990-08-01), Long
patent: 4987154 (1991-12-01), Long, Jr.
patent: 5114703 (1992-05-01), Wolf et al.
Chowdhary RK, "Influence of fluorocarbon emulsions on porphyrin-sensitised oxidation of histidine" Photochem Photbiol (England), 51:4 Abstract Only (1990).
Rosenblum "Fluorocarbon emulsions and cerebral microcirculation" Federation Proceedings 34:6 pp. 1493-1498 (1975).
Haegel, et al. "Selective incorporation of dyes with fluorocarbon and hydrocarbon chains into coexisting micellar phases of sodium perfluoroctoate and dimethyl tetradecyl aminosice" Progr Colloid Polyum Sci 76: pp. 132-139 (1988).
Kolodgie, et al. "Limitation of No Reflow Injury of Blood-Free Reperfusion With Oxygenated Perfluorochemical" (Fluosol-DA 20%) JACC 189:1 pp. 215-223.
Azzolini, et al. "Interactions Between Light and Vitreous Fluid Substitutes" Arch. Opthamol. 110: pp. 1345-1347 (1992).
Mizuiri "Laparoscopic examination of primary biliary cirrhosis after administration of indocyanine green" Gastroenterol Endosc. (with English Summary) 28: pp. 769-777 (1986).
Reed, et al. "A fluorescent dye which recognizes mature peripheral erythrocytes of myeloproliferative disorders" Cell Biol. Int. Rep 11:1 pp. 55-62 (1977).
Del Buono, et al. "Relation Between the Organization of Spectrin and of Membrane Lipids in Lymphocytes" J. Cell Biol. 106: pp. 797-703 (1988).
Levitt, et al. "Perfluorinated fatty acids alter merocyanine 540 dye binding to plasma membranes" J. Toxic. and Env. Health, 20: pp. 303-316 (1987).
Lutz, et al. "Devenir dans l'organisme et influence fonctionnelle des fluorocarbures utilised comme transporterus d'oxygene" Tomme XXIX, Revue Francaise de Transfusion et Immuno-Hematologie 6; pp. 443-453 (with English summary) (1986).
Lutz, et al. "Effects of Potential Blood Substitutes (Perfluorochemicals) on Rat Liver and Spleen" European Journal of Physiology 387:2 pp. 175-181 (1980).
Dorland's Medical Dictionary 27th Ed., p. 1845 (1988).
Alliance Pharmaceutical Corp.
Hollinden Gary E.
LandOfFree
Labeled fluorocarbon compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Labeled fluorocarbon compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Labeled fluorocarbon compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1884879